↓ Skip to main content

PD-1 blockade combined with gemcitabine plus nab-paclitaxel is superior to chemotherapy alone in the management of unresectable stage III/IV pancreatic cancer: a retrospective real-world study

Overview of attention for article published in Frontiers in oncology, October 2023
Altmetric Badge

Mentioned by

twitter
2 X users
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PD-1 blockade combined with gemcitabine plus nab-paclitaxel is superior to chemotherapy alone in the management of unresectable stage III/IV pancreatic cancer: a retrospective real-world study
Published in
Frontiers in oncology, October 2023
DOI 10.3389/fonc.2023.1281545
Pubmed ID
Authors

Daoan Cheng, Jing Hu, Xiaoyu Wu, Banglu Wang, Rui Chen, Weiqing Zhao, Cheng Fang, Mei Ji

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2023.
All research outputs
#20,930,935
of 25,707,225 outputs
Outputs from Frontiers in oncology
#11,510
of 22,767 outputs
Outputs of similar age
#256,943
of 363,370 outputs
Outputs of similar age from Frontiers in oncology
#340
of 908 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,767 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,370 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 908 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.